LAYQETA
LIVE

Serial Number

99637935

Owner

Glaxo Group Limited

Attorney

Elizabeth K. Rucki

Filing Date

Feb 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LAYQETA Trademark

Serial Number: 99637935

LAYQETA is a trademark filed by Glaxo Group Limited on February 6, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (40 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

February 6, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 11, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 11, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 11, 2026 CNSL
ASSIGNED TO EXAMINER
Feb 10, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 6, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
NEW APPLICATION ENTERED
Feb 6, 2026 NWAP